Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takahiko Murayama

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Drug resistance mechanisms of cancer stem-like cells and their therapeutic potential as drug targetsTakahiko Murayama, Noriko Gotoh
Cancer Discovery|April 2, 2025
Loss of p53 Induces Tolerance to Viral Mimicry as a Mechanism of Immune Evasion in Early TumorigenesisTakahiko Murayama, Israel Cañadas
Cells|June 23, 2019
Patient-Derived Xenograft Models of Breast Cancer and Their ApplicationTakahiko Murayama, Noriko Gotoh
Frontiers in Cell and Developmental Biology|May 7, 2026
Targeting R-loops: diverse RNA helicases in R-loop resolution and their potential as targets for cancer therapyKatherine Herrera, Kaoru Takasaki, Takahiko Murayama
Trends in Cancer|July 3, 2025
mtDNA transfer from senescent cancer cells to MDSCs promotes immunosuppressionIsrael Cañadas, Takahiko Murayama, Lorenzo Galluzzi
Cancer Research|February 4, 2016
Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell-like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine CircuitTakahiko Murayama, Takashi Nakaoku, Masato Enari, et al.
Molecular Cell|December 20, 2024
RNA sensing induced by chromosome missegregation augments anti-tumor immunityNobunari Sasaki, Mizuki Homme, Takahiko Murayama, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 24, 2021
Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myelomaMitsuhito Hirano, Yoichi Imai, Yuta Kaito, et al.
Oncogene|December 12, 2018
Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2Tatsunori Nishimura, Asuka Nakata, Xiaoxi Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2018
Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cellsKana Tominaga, Hiroshi Minato, Takahiko Murayama, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Drug resistance mechanisms of cancer stem-like cells and their therapeutic potential as drug targetsTakahiko Murayama, Noriko Gotoh
Cancer Discovery|April 2, 2025
Loss of p53 Induces Tolerance to Viral Mimicry as a Mechanism of Immune Evasion in Early TumorigenesisTakahiko Murayama, Israel Cañadas
Cells|June 23, 2019
Patient-Derived Xenograft Models of Breast Cancer and Their ApplicationTakahiko Murayama, Noriko Gotoh
Frontiers in Cell and Developmental Biology|May 7, 2026
Targeting R-loops: diverse RNA helicases in R-loop resolution and their potential as targets for cancer therapyKatherine Herrera, Kaoru Takasaki, Takahiko Murayama
Trends in Cancer|July 3, 2025
mtDNA transfer from senescent cancer cells to MDSCs promotes immunosuppressionIsrael Cañadas, Takahiko Murayama, Lorenzo Galluzzi
Cancer Research|February 4, 2016
Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell-like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine CircuitTakahiko Murayama, Takashi Nakaoku, Masato Enari, et al.
Molecular Cell|December 20, 2024
RNA sensing induced by chromosome missegregation augments anti-tumor immunityNobunari Sasaki, Mizuki Homme, Takahiko Murayama, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 24, 2021
Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myelomaMitsuhito Hirano, Yoichi Imai, Yuta Kaito, et al.
Oncogene|December 12, 2018
Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2Tatsunori Nishimura, Asuka Nakata, Xiaoxi Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2018
Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cellsKana Tominaga, Hiroshi Minato, Takahiko Murayama, et al.
Pageof 2